WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its President and CEO, Dr. Paul Ashton, will participate in a panel: “New Horizons in Glaucoma Drug Delivery and IOP Monitoring” at 10 a.m. PST, during the Glaucoma 360 New Horizons forum being held on Friday, February 3 at the Palace Hotel, in San Francisco. The conference is being presented by the Glaucoma Research Foundation in association with Ophthalmology Times® to “bring together nationally and internally respected leaders in medicine, science, business, venture capital, and philanthropy – all intent on transforming new ideas into new hope in the worldwide battle to beat glaucoma.”
